Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Eur J Pain. 2015 Oct 30;20(6):936–948. doi: 10.1002/ejp.818

Figure 2.

Figure 2

Transdermal cannabidiol (CBD) reduced monoarthritis-induced hind paw heat hypersensitivity. (A) Transdermal CBD significantly increased heat paw withdrawal latency in rats with monoarthritis, (B) but had no effect in naïve rats (*p < 0.01 vs. day 3, one-way ANOVA). (C, D) In the open-field test, transdermal CBD exerts no detectable effect on times spent in spontaneous exploratory activity or resting. (n = 5 per group and CBD dose)